MeiraGTx Holdings plc

NasdaqGS MGTX

MeiraGTx Holdings plc Dividend Yield on January 14, 2025: 0.00%

MeiraGTx Holdings plc Dividend Yield is 0.00% on January 14, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • MeiraGTx Holdings plc 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
  • MeiraGTx Holdings plc 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
  • MeiraGTx Holdings plc average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
NasdaqGS: MGTX

MeiraGTx Holdings plc

CEO Dr. Alexandria Forbes Ph.D.
IPO Date June 8, 2018
Location United States
Headquarters 430 East 29th Street
Employees 387
Sector Health Care
Industries
Description

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Similar companies

GBIO

Generation Bio Co.

USD 0.88

-4.35%

SLDB

Solid Biosciences Inc.

USD 3.09

-6.65%

QURE

uniQure N.V.

USD 13.23

-4.06%

ERAS

Erasca, Inc.

USD 1.93

-10.23%

CNTB

Connect Biopharma Holdings Limited

USD 1.06

-2.75%

RCKT

Rocket Pharmaceuticals, Inc.

USD 10.43

-2.80%

ETON

Eton Pharmaceuticals, Inc.

USD 13.42

-4.14%

EWTX

Edgewise Therapeutics, Inc.

USD 27.52

8.65%

NUVB

Nuvation Bio Inc.

USD 2.59

-3.00%

ELDN

Eledon Pharmaceuticals, Inc.

USD 3.71

-4.63%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

CCCC

C4 Therapeutics, Inc.

USD 3.74

6.86%

RYTM

Rhythm Pharmaceuticals, Inc.

USD 53.94

-1.73%

ANAB

AnaptysBio, Inc.

USD 14.91

1.98%

IDYA

IDEAYA Biosciences, Inc.

USD 22.74

-1.00%

KROS

Keros Therapeutics, Inc.

USD 12.48

-2.65%

StockViz Staff

January 15, 2025

Any question? Send us an email